Environmental Enrichment and Gene–Environment Interactions in Mouse Models of Brain Disorders

CrossRefPubMed




2.

van Praag H, Kempermann G, Gage FH (2000) Neural consequences of environmental enrichment. Nat Rev Neurosci 1:191-198CrossRefPubMed


3.

Grote HE, Hannan AJ (2007) Regulators of adult neurogenesis in the healthy and diseased brain. Clin Exp Pharmacol Physiol 34:533-545CrossRefPubMed


4.

Laviola G, Hannan AJ, Macrì S, Solinas M, Jaber M (2008) Effects of enriched environment on animal models of neurodegenerative and psychiatric disorders. Neurobiol Dis 31:159-168CrossRefPubMed


5.

Nithianantharajah J, Hannan AJ (2007) Dynamic mutations as digital genetic modulators of brain development, function and dysfunction. Bioessays 29:525-535CrossRefPubMed


6.

Bates G, Harper PS, Jones L (eds) (2002) Huntington’s disease, 3rd edn. Oxford University Press, Oxford, England


7.

Feigen VL, Bennett DA (2007) Handbook of clinical neuroepidemiology. Nova Science Publishers, New York, USA


8.

van Dellen A, Blakemore C, Deacon R et al (2000) Delaying the onset of Huntington’s in mice. Nature 404:721-722CrossRefPubMed


9.

Hockly E, Cordery P, Woodman B et al (2002) Environmental enrichment slows disease progression in R6/2 Huntington’s disease mice. Ann Neurol 51:235-242CrossRefPubMed


10.

Spires TL, Grote HE, Varshney NK et al (2004) EE rescues protein deficits in a mouse model of Huntington’s disease, indicating a possible disease mechanism. J Neurosci 24:2270-2276CrossRefPubMed


11.

Spires TL, Grote HE, Garry S et al (2004) Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington’s disease transgenic mice. Eur J Neurosci 19:2799-2807CrossRefPubMed


12.

Glass M, van Dellen A, Blakemore C et al (2004) Delayed onset of Huntington’s disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors. Neuroscience 123:207-212CrossRefPubMed


13.

Schilling G et al (2004) Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice. Exp Neurol 187:137-149CrossRefPubMed


14.

Nithianantharajah AJ, Barkus C, Murphy M, Hannan AJ (2008) Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington’s disease transgenic mice. Neurobiol Dis 29:490-504CrossRefPubMed


15.

Pang TYC, Du X, Zajac MS et al (2009) Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington’s disease. Hum Mol Genet 18:753-766CrossRefPubMed


16.

Lazic SE, Grote H, Armstrong RJ et al (2004) Decreased hippocampal cell proliferation in R6/1 Huntington’s mice. Neuroreport 15:811-813CrossRefPubMed


17.

Grote HE, Bull ND, Howard ML et al (2005) Cognitive disorders and neurogenesis deficits in Huntington’s disease mice are rescued by fluoxetine. Eur J Neurosci 22:2081-2088CrossRefPubMed


18.

Pang TY, Stam NC, Nithianantharajah J et al (2006) Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington’s disease transgenic mice. Neuroscience 141:569-584CrossRefPubMed


19.

Lazic SE, Grote HE, Blakemore C et al (2006) Neurogenesis in the R6/1 transgenic mouse model of Huntington’s disease: effects of environmental enrichment. Eur J Neurosci 23:1829-1838CrossRefPubMed


20.

Nithianantharajah J, Vijiaratnam N, Barkus C, et al (2009) Modeling brain reserve: experience-dependent neuronal plasticity in healthy and Huntington’s disease transgenic mice. Am J Ger Psychiatry 17:196-209


21.

van Dellen A, Cordery PM, Spires TL et al (2008) Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington’s disease. BMC Neurosci 9:34CrossRefPubMed


22.

Wexler NS, Lorimer J, Porter J et al (2004) U.S.-Venezuela Collaborative Research Project. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington’s disease age of onset. Proc Natl Acad Sci USA 101:3498-3503CrossRefPubMed


23.

Masters CL, Cappai R, Barnham KJ, Villemagne VL (2006) Molecular mechanisms for Alzheimer’s disease: implications for neuroimaging and therapeutics. J Neurochem 97:1700-1725CrossRefPubMed

Apr 2, 2017 | Posted by in NEUROSURGERY | Comments Off on Environmental Enrichment and Gene–Environment Interactions in Mouse Models of Brain Disorders

Full access? Get Clinical Tree

Get Clinical Tree app for offline access